This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Ocular Drug Therapies / Oral Delivery of Macromolecules
October 26-27, 2022 | 2-Day Digital Conference
Digital Conference8:00AM EST // 1:00PM BST // 2:00PM CEST
Menu

Jay Duker
Chief Operating Officer at EyePoint Pharmaceuticals, USA
Speaker

Agenda Sessions

  • Sustained Release of Anti-VEGF TKI using Bio-erodible Implant for the Treatment of Wet Age-Related Macular Degeneration and Other Retina Conditions

    09:35
    View Session

At this event

Prev
Next
D. Scott Edwards
Chief Development Operating Officer
OcuTerra Therapeutics, Inc., USA

See Jay at Ocular Drug Therapies / Oral Delivery of Macromolecules